66.33 +0.12 (0.18%)
CELG
Stock Details
Last Trade:66.33 Change:+0.12 (0.18%) Prev Close:66.21 Open: 67.17 Days Range:65.76 – 67.49 52 Week Range: 41.26 - 77.39 Volume:2440053 P/E: N/AEPS:-3.45
View AllRecent Alerts 09/08/08
Recent Alert on 09/08/08 at 9:04am
Citi Maintains 'Buy' on Celgene Corp (CELG), Sell-Off Overdone
Citi Maintains 'Buy' on Celgene Corp (CELG), Sell-Off Overdone
Citi maintains a 'Buy' rating on Celgene (Nasdaq: CELG). Price target $81. Citi analyst says, "We believe today's sell off due to FDA's new quarterly review of AERS that posts Revlimid as potentially having an association with Stevens Johnson is... Read More
Recent Alert on 09/02/08 at 7:43am
Celgene (CELG) Announces Publication of Positive Results from Phase II Study of REVLIMID
Celgene (CELG) Announces Publication of Positive Results from Phase II Study of REVLIMID
View AllRecent Press Releases
Press Release on 09/05/08 at 7:30am
Celgene Corporation to Present at Morgan Stanley Global Healthcare Unplugged Conference
Celgene Corporation to Present at Morgan Stanley Global Healthcare Unplugged Conference
Press Release on 09/04/08 at 8:35am
Amrubicin Receives FDA Fast Track Designation for the Treatment of Small Cell Lung Cancer after First-Line Chemotherapy
Amrubicin Receives FDA Fast Track Designation for the Treatment of Small Cell Lung Cancer after First-Line Chemotherapy
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 08/13/08 at 6:49am
24/7 Wall St. Biotech Report: Short-Selling And Splits (AMGN)(CELG)
24/7 Wall St. Biotech Report: Short-Selling And Splits (AMGN)(CELG)
Blog Posts on 08/04/08 at 8:18am
KV Pharmaceutical's Motion for Rule 11 Sanctions in Ritalin LA Case Denied
KV Pharmaceutical's Motion for Rule 11 Sanctions in Ritalin LA Case Denied